Read the full stored bill text
MURIEL BOWSER
MAYOR
June 11, 2025
Honorable Phil Mendelson
Chairman
Council of the District of Columbia
John A. Wilson Building
1350 Pennsylvania Avenue, NW, Suite 504
Washington, DC 20004
Dear Chairman Mendelson:
Pursuant to section 451 of the District of Columbia Home Rule Act (D.C. Official Code § 1-
204.51) and section 202 of the Procurement Practices Reform Act of2010 (D.C. Official Code§
2-352.02), enclosed for consideration and approval by the Council of the District of Columbia is
proposed Modification No. M00l0 to Contract No. CW94739 with Ramsell Corporation, which
will increase the not-to-exceed (NTE) amount of the contract by $3,000,000 revising the total
ceiling amount to 13,500,000.
Under the proposed modification, Ramsell Corporation will continue providing a Pharmacy
Benefit Management System for DC Health's Aids Drug Assistance Program, the Pre-Exposure
Prophylaxis and Post exposure Prophylaxis program, and the Medication Assisted Therapy
program.
My administration is available to discuss any questions you may have regarding the proposed
contract modification. In order to facilitate a response to any questions you may have, please
have your staff contact Marc Scott, Chief Operating Officer, Office of Contracting and
Procurement, at (202) 724-8759.
I look forward to the Council's favorable consideration of this contract modification.
1
GOVERNMENT OF THE DISTRICT OF COLUMBIA
Office of Contracting and Procurement
Pursuant to section 202(c) of the Procurement Practices Reform Act of 2010, as amended, D.C.
Official Code § 2-352.02(c), the following contract summary is provided:
COUNCIL CONTRACT SUMMARY
Contract Modification
(A) Contract Number: CW94739
Proposed Contractor: Ramsell Corporation (Ramsell)
Proposed Contractor’s Principals:
1. Eric Flowers – Chief Executive Officer
2. Sophia J. Byndloss – Chief Operating Officer
3. Darcy Illg – Chief Financial Officer
Contract Amount: Not-to-exceed (NTE) $13,500,000
Unit and Method of Compensation: Monthly fee for premiums and co-payment management
Term of Contract: January 18, 2025, through January 17, 2026
Type of Contract: Firm-Fixed Price with a Cost Reimbursement component
Source Selection Method: Invitation for Bids
(B) For a contract containing option periods, the contract amount for the base period and for
each option period. If the contract amount for one or more of the option periods differs from
the amount for the base period, provide an explanation of the reason for the difference:
Base Period Amount: NTE $7,514,944
Council Approval No. CA24-0362
Option Period One Amount: NTE $7,530,851.32
Council Approval No. R25-0085
Explanation of difference from base period (if applicable):
2
The contract amount for option period one differs from the base period amount due to an overall
increase in costs associated with providing the Pharmacy Benefit Management System (PBMS), and
ongoing maintenance and support services including, labor, taxes, overhead, and general operating
expenses.
Option Period Two Amount: NTE $9,547,235.86
Council Approval No. CA25-0876
Explanation of difference from base period (if applicable):
The contract amount for option period two reflects an increase in costs associated with inflated
insurance rates and the dissolution of subsidies previously provided for by the Affordable Cares Act
Option Period Three Amount: NTE $13,500,000
Council Approval No. R26-0049 - NTE $10,500,000
Seeking Council approval to increase option period three by $3,000,000
Explanation of difference from base period (if applicable):
The increment is due to a projected increase in drug expenditure for Biktarvy due to higher client
usage and escalating drug costs.
Option Period Four Amount: NTE $13,500,000
Explanation of difference from base period (if applicable):
The increment is due to a projected increase in drug expenditure for Biktarvy due to higher client
usage and escalating drug costs.
(C) The goods or services to be provided, the methods of delivering goods or services, and any
significant program changes reflected in the proposed contract:
The Government of the District of Columbia Office of Contracting and Procurement, on behalf of the
Department of Health (DC Health) has a continued need to provide a PBMS for DC Health’s Aids
Drug Assistance Program, the Pre-Exposure Prophylaxis and Post exposure Prophylaxis program ,
and the Medication Assisted Therapy program. These programs provide access to prescription
coverage and health care for District residents infected with Human Immunodeficiency Virus (HIV)
who are uninsured or underinsured.
The PBMS shall include medication inventory management, health insurance premium and co-
payment assistance, an interface with Health Resources and Services Administration’s data
reporting systems, and support to District pharmacy providers to develop methods of improving and
tracking medication adherence.
Under proposed modification M0010, DC Health seeks approval to increase option year three by
$3,000,000 to a not-to-exceed amount of $13,500,000 in response to an unforeseen increase in costs.
3
(D) The selection process, including the number of offerors, the evaluation criteria, and the
evaluation results, including price, technical or quality, and past performance components:
An Invitation for Bids (IFB), Doc575975, was issued on August 17, 2021, as an open market
IFB, in accordance with 27 DCMR 1600. The IFB was publicized in the Washington Times on
August 19, 2021, and OCP’s website via e- Sourcing on August 17, 2021. It closed on September
10, 2021, and resulted in one bid received from Ramsell.
Ramsell’s bid was evaluated based on the bid submission requirements listed in the IFB, including
proof of experience, past performance, contracts with District pharmacies, and system compliances.
Ramsell met all the bid submission requirements; therefore, the contracting officer deemed them the
lowest responsive, responsible bidder.
(E) A description of any bid protest related to the award of the contract, including whether the
protest was resolved through litigation, withdrawal of the protest by the protestor, or
voluntary corrective action by the District. Include the identity of the protestor, the grounds
alleged in the protest, and any deficiencies identified by the District as a result of the protest:
None
(F) A description of any other contracts the proposed contractor is currently seeking or holds
with the District:
None
(G) The background and qualifications of the proposed contractor, including its organization,
financial stability, personnel, and performance on past or current government or private
sector contracts with requirements similar to those of the proposed contract:
Ramsell has been providing this service to the District for over six years . Ramsell has demonstrated
its qualifications including its organization, financial stability, personnel, and performance on current
and past contracts with similar requirements. Ramsell has adequate financial resources to perform the
contract or the ability to obtain those resources, based on its Bidder/Offeror Certification Form, and
Dun and Bradstreet report. Past performance evaluations from the District and other government
sectors reflect high quality services and customer satisfaction.
(H) A summary of the subcontracting plan required under section 2346 of the Small, Local, and
Disadvantaged Business Enterprise Development and Assistance Act of 2005, as amended,
D.C. Official Code § 2-218.01 et seq. (“Act”), including a certification that the subcontracting
plan meets the minimum requirements of the Act and the dollar volume of the portion of the
contract to be subcontracted, expressed both in total dollars and as a percentage of the total
contract amount:
The Department of Small and Local Business Development waived the 35% subcontracting
requirement on November 8, 2024.
4
(I) Performance standards and the expected outcome of the proposed contract:
The expected outcome of the proposed contract is to continue providing maintenance and support
services for PBMS so District residents infected with HIV will continue to receive access to
prescription coverage and health care. The District expects Ramsell to comply with the performance
standards and guarantees set forth in the contract.
(J) The amount and date of any expenditure of funds by the District pursuant to the contract
prior to its submission to the Council for approval:
None
(K) A certification that the proposed contract is within the appropriated budget authority for the
agency for the fiscal year and is consistent with the financial plan and budget adopted in
accordance with D.C. Official Code §§ 47-392.01 and 47-392.02:
The Agency Financial Officer has certified that funds in the amount of $13,500,000 are available to
continue maintenance and support services for PBMS.
(L) A certification that the contract is legally sufficient, including whether the proposed
contractor has any pending legal claims against the District:
The contract has been determined legally sufficient. The contractor has no pending legal claims
against the District.
(M) A certification that Citywide Clean Hands database indicates that the proposed contractor is
current with its District taxes. If the Citywide Clean Hands Database indicates that the
proposed contractor is not current with its District taxes, either: (1) a certification that the
contractor has worked out and is current with a payment schedule approved by the District;
or (2) a certification that the contractor will be current with its District taxes after the District
recovers any outstanding debt as provided under D.C. Official Code § 2-353.01(b):
The Citywide Clean Hands database certified that the contractor is current with its District taxes.
(N) A certification from the proposed contractor that it is current with its federal taxes, or has
worked out and is current with a payment schedule approved by the federal government:
The contractor has self-certified via the Bidder/Offeror Certification form that it is current with its
federal taxes.
(O) A certification that the proposed contractor has been determined not to violate section 334a of
the Board of Ethics and Government Accountability Establishment and Comprehensive
Ethics Reform Amendment Act of 2011, D.C. Official Code § 1-1163.34a; and (2) A
certification from the proposed contractor that it currently is not and will not be in violation
of section 334a of the Board of Ethics and Government Accountability Establishment and
Comprehensive Ethics Reform Amendment Act of 2011, D.C. Official Code § 1-1163.34a:
5
The contractor has certified, via the Bidder/Offeror Certification form, that it is (1) not in violation
of section 334a of the Board of Ethics and Government Accountability Establishment and
Comprehensive Ethics Reform Amendment Act of 2011, D.C. Official Code § 1-1163.34a; and (2)
currently is not and will not be in violation of section 334a of the Board of Ethics and Government
Accountability Establishment and Comprehensive Ethics Reform Amendment Act of 2011, D.C.
Official Code § 1-1163.34a.
(P) The status of the proposed contractor as a certified local, small, or disadvantaged business
enterprise as defined in the Small, Local, and Disadvantaged Business Enterprise
Development and Assistance Act of 2005, as amended; D.C. Official Code § 2-218.01 et seq.:
The contractor is not a certified local, small or disadvantage business enterprise.
(Q) Other aspects of the proposed contract that the Chief Procurement Officer considers
significant:
None
(R) A statement indicating whether the proposed contractor is currently debarred from providing
services or goods to the District or federal government, the dates of the debarment, and the
reasons for debarment:
The contractor does not appear on the Office of Inspector General Exclusions Database, the Federal
Excluded Parties List or the District’s list of Debarred and Suspended contractors.
(S) Any determination and findings issues relating to the contract’s formation, including any
determination and findings made under D.C. Official Code § 2-352.05 (privatization
contracts):
Determination and Findings for Contractor Responsibility dated May 1, 2025
Determination and Findings for Price Reasonableness dated May 1, 2025
Determination and Findings for Cost Reimbursement dated October 15, 2021
(T) Where the contract, and any amendments or modifications, if executed, will be made
available online:
Office of Contracting and Procurement website http://ocp.dc.gov
(U) Where the original solicitation, and any amendments or modifications, will be made available
online:
Office of Contracting and Procurement website http://ocp.dc.gov
1101 4th Street, SW
Washington, DC 20024
Date of Notice: April 14, 2025 L0014086146Notice Number:
FEIN: **-***4229
Case ID: 18560985
Government of the District of Columbia
Office of the Chief Financial Officer
Office of Tax and Revenue
RAMSELL CORPORATION
2300 CLAYTON RD STE 1490
CONCORD CA 94520-2197
Branch Chief, Collection and Enforcement Administration
Authorized By Melinda Jenkins
To validate this certificate, please visit MyTax.DC.gov. On the MyTax DC homepage, click the
“Validate a Certificate of Clean Hands” hyperlink under the Clean Hands section.
CERTIFICATE OF CLEAN HANDS
As reported in the Clean Hands system, the above referenced individual/entity has no outstanding
liability with the District of Columbia Office of Tax and Revenue or the Department of Employment
Services. As of the date above, the individual/entity has complied with DC Code § 47-2862, therefore
this Certificate of Clean Hands is issued.
TITLE 47. TAXATION, LICENSING, PERMITS, ASSESSMENTS, AND FEES
CHAPTER 28 GENERAL LICENSE
SUBCHAPTER II. CLEAN HANDS BEFORE RECEIVING A LICENSE OR PERMIT
D.C. CODE § 47-2862 (2006)
§ 47-2862 PROHIBITION AGAINST ISSUANCE OF LICENSE OR PERMIT
1101 4th Street SW, Suite W270, Washington, DC 20024/Phone: (202) 724-5045/MyTax.DC.gov
COPY
2201 Shannon Place SE 4th Washington, D.C. 20020 -5955
Department of Health
MEMORANDUM
Government of the District of Columbia
Office of the Chief Financial Officer
TO: Nancy Hapeman
Chief Procurement Officer
Office of Contracting and Procurement
THRU: Delicia V. Moore
Associate Chief Financial Officer
Human Support Services Cluster
FROM:
DATE:
Adreana Deane
Agency Fiscal Officer
Department of Health
April 25, 2025
SUBJECT: Certification of Funding Availability for Ramsell, Contract #CW94739
The Office of the Chief Financial Officer hereby certifies that the sum of $7,971,000.00 is included in the
5, pending the councils
passive approval for award 2002846. The contract funds costs are associated with Ramsell to
provide pharmacy benefits management, prescription drug payments and health insurance
premium services. An additional $5,529,000.00 of funding for Fiscal Year 2026 is dependent on
a final approved budget, reprogramming and FY25 carryover budget adjustment. This
certification supports the Ramsell contract during the period from January 18, 2025 to January
17, 2026 for a total of $13,500,000.00. This certification is dependent upon approval of the
-053. Funds will be sufficient to pay for
fees and costs associated with the contract. There is no fiscal impact associated with the contract.
The fund allocation is as follows:
Vendor: Ramsell, LLC Contract #: CW94739
Fiscal Year 2025 Funding Period: 01/18/25 to 03/31/25
FY Agency
Code
Fund Program Cost
Center
Account Award Project Task/Sub
task
Amount
2025 HC0 4020002 700035 70079 7132001 2001608 200824 24.03 $1,297 ,000.00
2201 Shannon Place SE 4th Washington, D.C. 20020 -5955
Fiscal Year 2025
Funding Period: 01/18/2025 to 09/30/2025
FY Agency
Code
Fund Program Cost
Center
Account Award Project Task/Sub
task
Amount
2025 HC0 1060188 700041 70079 7132001 6000037 202184 30.40 $722 ,000.00
Fiscal Year 2025 Funding Period: 04/01/2025 to 09/30/2025
FY Agency
Code
Fund Program Cost
Center
Account Award Project Task/Sub
task
Amount
2025 HC0 4020002 700035 70079 7132001 2002846 203255 30.60 $650,133.00
2025 HC0 4020002 700035 70079 7132001 2001810 200824 30.60 $5,301,867 .00
TOTAL FY 2025: $7,971,000.00
Fiscal Year 2026 Funding Period: 10/01/2025 to 01/17/2026
FY Agency
Code
Fund Program Cost
Center
Account Award Project Task/Sub
task
Amount
2026 HC0 1060188 700035 70078 7132001 6000037 202184 30.61 $900,000.00
2026 HC0 4020002 700037 70078 7132001 2001813 200819 30.20 $550,000.00
2026 HC0 4020002 700035 70079 7132001 2001810 200824 30.60 $4,079,000.00
TOTAL FY 2026: $5,529,000.00
Should you have any questions, please contact me at 202-442-9222.
400 6th Street NW, Suite 9100, Washington, DC 20001 (202) 727-3400
GOVERNMENT OF THE DISTRICT OF COLUMBIA
Office of the Attorney General
ATTORNEY GENERAL
BRIAN L. SCHWALB
Commercial Division
MEMORANDUM
TO: Tomás Talamante
Director
Office of Policy and Legislative Affairs
FROM: Robert Schildkraut
Section Chief
Government Contracts Section
DATE: May 29, 2025
SUBJECT: Approval of Contract Action : DC ADAP Pharmacy Benefit Program
Contract Number: CW94739
Contractor: Ramsell Corporation
Proposed Modification Amount: Not-to-Exceed $3,000,000 (to $13,500,000)
This is to Certify that this Office has reviewed the above- referenced Contract and that we have
found it to be legally sufficient. If you have any questions in this regard, please do not hesitate to
call me at (202) 724-4018.
______________________________
Robert Schildkraut
1 | Page
AMENDMENT OF SOLICITATION / MODIFICATION OF CONTRACT 1. Contract Number Page of Pages
CW94739
1 2
2. Amendment/Modification Number 3. Effective Date 4. Requisition/Purchase Request No. 5. Solicitation Caption
M0010
See 16C
DOH HAHSTA PBMS
6. Issued by: Code HCONM 7. Administered by (If other than line 6)
The District of Columbia
Office of Contracting and Procurement
441 4th Street, NW, suite 700 South
Washington, DC 20001
Department of Health
2201 Shannon Place, SE
Washington DC 20020
8. Name and Address of Contractor (No. Street, city, county, state and zip
code)
Ramsell Corporation
200 Webster Street, Ste. 200
Oakland CA 94607
Point of Contact: Sophia Byndloss
Email: sbyndloss@ramsellcorp.com
9A. Amendment of Solicitation No.
9B. Dated (See Item 11)
X
10A. Modification of Contract/Order No.
CW94739
Code
Facility
10B. Dated (See Item 13)
January 18, 2022
11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
The above numbered solicitation is amended as set forth in item 14. The hour and date specified for receipt of Offers is extended. is not extended.
Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following
methods: (a) By completing Items 8 and 15 and returning one (1) copy of the amendment: (b) By acknowledging receipt of this amendment on each
copy of the offer submitted; or (c) BY separate letter or fax which includes a reference to the solicitation and amendment number. FAILURE OF YOUR
ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE
SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such
may be made by letter or fax, provided each letter or telegram makes reference to the solicitation and this amendment, and is received prior to the
opening hour and date specified.
12. Accounting and Appropriation Data (If Required)
13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS,
IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14
X A. This change order is issued pursuant to (Specify Authority): 27 DCMR, CHPATER 36; Section 3601.2(b). The changes set forth in Item 14
are made in the contract/order no. in Item 10A
B. The above numbered contract/order is modified to reflect the administrative changes (such as changes in paying office, appropriation data
etc.) set forth in item 14, pursuant to the authority of 27 DCMR, Chapter 36, Section 3601.2.
C. This supplemental agreement is entered into pursuant to authority of: DC Official Code 2-354-04 and 27 DCMR 3601.2 Mutual Agreement
of Parties
D. Other (Specify type of modification and authority)
E. IMPORTANT: Contractor is not is required to sign this document and return ___1___ copy to the issuing office.
14. Description of Amendment/Modification (Organized by UCF Section headings, including solicitation/contract subject matter where feasible.)
Contract No. CW94739 is hereby modified as follows:
A. Increase the contract ceiling amount by $3,000,000 for option period three and option period four revising
the total ceiling amount for both periods to $13,500,000.
B. Replace Sections B.3.7, B.3.8, B.3.9, B.3.10 and B.4 - Price Schedule with the Revised Price Schedule below.
REVISED PRICE SCHEDULE
B.3.7 – Option Year Three – Firm Fixed Price
Contract Line-Item
Number (CLIN) Description of Services Total Price
3001 Pharmacy Benefit Management System $579,411.94
B.3.8 Option Year Three – Cost Reimbursements
CLIN Description of Services Not-To-Exceed (NTE) Cost
3002 Insurance Premium Payments (C.5.4) $1,621,323.92
2 | Page
3003 Prescription Co-Payments (C.5.6) $586,500.00
3004 Pharmacy Provider Ingredient Cost and Dispensing Fees (C.5.8) $10,312,764.14
3005 Rebate Processing Fees (C.5.2.13) $400,000.00
Total Cost Reimbursements) $12,920,588.06
Total NTE Amount (Fixed Prices + Cost Reimbursements) $13,500,000
B.3.9 Option Year Four – Firm Fixed Price
Contract Line-Item
Number (CLIN) Description of Services Total Price
4001 Pharmacy Benefit Management System $596,794.29
B.3.10 Option Year Four – Cost Reimbursements
CLIN Description of Services Not-To-Exceed (NTE) Cost
4002 Insurance Premium Payments (C.5.4) $1,603,941.57
4003 Prescription Co-Payments (C.5.6) $586,500.00
4004 Pharmacy Provider Ingredient Cost and Dispensing Fees (C.5.8) $10,312,764.14
4005 Rebate Processing Fees (C.5.2.13) $400,000.00
Total Cost Reimbursements) $12,903,205.71
Total NTE Amount (Fixed Prices + Cost Reimbursements) $13,500,000
B.4 - PRICE SCHEDULE SUMMARY – BASE AND OPTION YEARS
B.3.1 (BASE YEAR) $7,514,944
B.3.2 (OPTION YEAR ONE) $7,530,851.32
B.3.3 (OPTION YEAR TWO) $10,500,000
B.3.4 (OPTION YEAR THREE) $13,500,000
B.3.5 (OPTION YEAR FOUR) $13,500,000
GRAND TOTAL FOR ALL YEARS $52,545,795
Except as provided herein, all terms and conditions of the document is referenced in Item 9A or 10A remain unchanged and in full force and effect.
15A. Name and Title of Signer (Type or print) 16A. Name of Contracting Officer
Monica Bailey-Delissaint
15B. Name of Contractor
(Signature of person authorized to sign)
15C. Date Signed 16B. District of Columbia
(Signature of Contracting Officer)
16C. Date Signed
Sophia J. Byndloss
4/30/2025